Clinical trials
Psychotic Disorders trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 8 |
| Bispebjerg Hospital | 2 |
| Lone Baandrup | 2 |
| Rigshospitalet, Denmark | 2 |
| Amager Hospital | 1 |
| Anne Katrine Pagsberg | 1 |
| Birte Glenthoj | 1 |
| Bjorn H. Ebdrup | 1 |
| Brigham and Women's Hospital | 1 |
| European Group for Research In Schizophrenia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 28 |
| Schizophrenia | 20 |
| Bipolar Disorder | 6 |
| Schizotypal Personality Disorder | 6 |
| Mental Disorders | 5 |
| Cognitive Dysfunction | 2 |
| Depressive Disorder | 2 |
| Marijuana Abuse | 2 |
| Schizophrenia, Paranoid | 2 |
| Borderline Personality Disorder | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.